Rooftop solar panels are becoming an increasingly important part of the energy strategies for organisations in the pharmaceutical sector, reports specialist electrical and solar panel contractors, Fusion 360.
Where are the biggest points of friction between drug development and commercial manufacturing today, and how can the industry remove them? FUJIFILM Biotechnologies, Systech and Pace Life Sciences discuss.
David Garratt, principal consultant - Automated IT Governance, Risk, Compliance, Verista looks at building a practical AI governance foundation in regulated industries.
Timothy Steckler, Ph.D., applications technology manager and Benny David, Ph.D., director, global business development at NuSil explore how silicone materials are expanding the formulator's toolbox.
Editor Olivia Friett explores a question facing pharmaceutical manufacturing today: when does complexity stop adding value and start getting in the way?
Giuseppe De Franza, director of research & development Italy, Adare Pharma Solutions, explores cushioning strategies for multiple-unit pellet system tablets.
Teresa Barata, PhD, chief scientific officer at FairJourney Bio, spoke to Olivia Friett, editor of European Pharmaceutical Manufacturer, about The Antibody Series, held on 16–18 September in Évora, Portugal.
David Fernández Bleda, global head EHS operations and Pere Hernandez, global EHS API projects manager, ESTEVE CDMO explore the human side of HPAPI safety.
